Pierre Fabre

About Pierre Fabre

Laboratoires Pierre Fabre, held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning: the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group: A pharmaceutical group with a strong positioning: medical and natural. The second largest dermo-cosmetics laboratory in the world. The second largest private French pharmaceutical group. The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including: Pharmaceutical Care, Pierre Fabre Oncologie, Pierre Fabre Dermatologie, Naturactive, Eau Thermale Avène, Klorane, Ducray, René Furterer, A-Derma, Pierre Fabre Oral Care, Glytone (US), Darrow (Brasil). Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France. Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business. Pierre Fabre Group has a unique company structure. 86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan. In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level: Excellence being the highest maturity level of the ECOCERT 26000 standard.